Biodexa Pharmaceuticals Plc logo

BDRXBiodexa Pharmaceuticals Plc

BDRX Stock Price, Valuation & Chart | Biodexa Pharmaceuticals Plc

Compare

BDRX Historical price chart

BDRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization585.62K
PE Ratio-934.4
EPS0.0
Trading Volume52.31K
Today's High/Low0.79/0.76
Dividend Yield0.00
52 Week High/Low59.4/0.76
Shares Outstanding746.11K
BDRX Financial Statement
BDRX Analyst ratings
BDRX Analysis & performance metrics

BDRX Company profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis,…

BDRX Management team

Management
Stephen Anthony StampCEO
Chief Executive Officer, Chief Financial Officer, Company Secretary & Director
Steve Ellul
Chief Business Officer
Gary A. Shangold CPI, FACOG, M.D.
Chief Medical Officer
Fiona Sharp
Group Financial Controller
Daniel Palmer MBA, Ph.D.
Vice President of Technology
Total 5 executives

BDRX Frequently asked questions

What is Biodexa Pharmaceuticals Plc (BDRX) Stock Price?

Current stock price of Biodexa Pharmaceuticals Plc (BDRX) stock is $0.780. The stock price is +0.53% higher in the session. The intraday range can be seen from this page. Volume of Biodexa Pharmaceuticals Plc (BDRX) stock is 52.31K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Biodexa Pharmaceuticals Plc (BDRX) stock price going up or down today?

The stock price of Biodexa Pharmaceuticals Plc (BDRX) can change with earnings, company news, and overall market sentiment. Biodexa Pharmaceuticals Plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Biodexa Pharmaceuticals Plc stock expensive at its current price?

Whether Biodexa Pharmaceuticals Plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BDRX on this page is -934.40. EPS on this page is 0.00. Compare those figures with peers and growth expectations before deciding if the current Biodexa Pharmaceuticals Plc price is justified.

How has the stock price of Biodexa Pharmaceuticals Plc (BDRX) performed historically?

Historical performance for Biodexa Pharmaceuticals Plc (BDRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BDRX reacted to past earnings and market events.

Should I buy Biodexa Pharmaceuticals Plc (BDRX) stock, at this price?

Buying Biodexa Pharmaceuticals Plc (BDRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.